1. Sibai, BM, Stella, CL. Gynecology: diagnosis and management of atypical preeclampsia-eclampsia. Am J Obstet Gynecol 2009; 200:481
Google Scholar | Crossref | Medline2. Rana, S, Lemoine, E, Granger, JP, Karumanchi, SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res 2019; 124:1094–112
Google Scholar | Crossref | Medline3. Program NHBPE . Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183:s1–s22
Google Scholar | Crossref | Medline4. Zeng, Y, Li, M, Chen, Y, Wang, S. Homocysteine, endothelin-1 and nitric oxide in patients with hypertensive disorders complicating pregnancy. Int J Clin Exp Pathol 2015; 8:15275
Google Scholar | Medline5. Hasegawa, J, Ikeda, T, Sekizawa, A, Tanaka, H, Nakata, M, Murakoshi, T, Katsuragi, S, Osato, K, Ishiwata, I, Kinoshita, K. Maternal death exploratory C, Japan association of O, gynecologists: maternal death due to stroke associated with pregnancy-induced hypertension. Circ J 2015; 79:1835–40
Google Scholar | Crossref | Medline6. Roberts, CL, Algert, CS, Morris, JM, Ford, JB, Henderson-Smart, DJ. Hypertensive disorders in pregnancy: a population-based study. Med J Aust 2005; 182:332–5
Google Scholar | Crossref | Medline | ISI7. Chau, K, Hennessy, A, Makris A. Placental growth factor and pre-eclampsia. J Hum Hypertens 2017; 31:782–6
Google Scholar | Crossref | Medline8. Torry, DS, Wang, HS, Wang, TH, Caudle, MR, Torry, RJ. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 1998; 179:1539–44
Google Scholar | Crossref | Medline9. Livingston, JC, Chin, R, Haddad, B, McKinney, ET, Ahokas, R, Sibai, BM. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. Am J Obstet Gynecol 2000; 183:1554–7
Google Scholar | Crossref | Medline10. Pinheiro, CC, Rayol, P, Gozzani, L, Reis, LM, Zampieri, G, Dias, CB, Woronik, V. The relationship of angiogenic factors to maternal and neonatal manifestations of early-onset and late-onset preeclampsia. Prenat Diagn 2014; 34:1084–92
Google Scholar | Crossref | Medline11. Cerdeira, AS, Karumanchi, SA. Angiogenic factors in preeclampsia and related disorders. Cold Spring Harb Perspect Med 2012; 2: a006585
Google Scholar | Crossref | Medline12. Park, JE, Chen, HH, Winer, J, Houck, KA, Ferrara, N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to flt-1 but not to flk-1/KDR. J Biol Chem 1994; 269:25646–54
Google Scholar | Crossref | Medline | ISI13. Niki, K, Sugawara, M, Chang, D, Harada, A, Okada, T, Sakai, R, Uchida, K, Tanaka, R, Mumford, CE. A new noninvasive measurement system for wave intensity: evaluation of carotid arterial wave intensity and reproducibility. Heart Vessels 2002; 17:12–21
Google Scholar | Crossref | Medline | ISI14. Li, J, Wang, B, Cai, A, Yuan, Q, Ding, H, Zhao, D. Carotid arterial wall stiffness correlates positively with impedance of the umbilical and uterine arteries in women with preeclampsia. J Clin Ultrasound 2019; 47:27–35
Google Scholar | Crossref | Medline15. Mei, X, Si, H. Evaluations of carotid artery elasticity in patients with hypertensive disorders in pregnancy by echo tracking technique. Inner Mongolia Medical Journal 2010;8:371
Google Scholar16. Gynecologists ACoOa: Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol 2013; 122:1122–31
Google Scholar | Medline17. Failla, CM, Carbo, M, Morea, V. Positive and negative regulation of angiogenesis by soluble vascular endothelial growth factor receptor-1. Int J Mol Sci 2018; 19:1306
Google Scholar | Crossref18. Kleinrouweler, CE, Wiegerinck, MM, Ris-Stalpers, C, Bossuyt, PM, van der Post, JA, von Dadelszen, P, Mol, BW, Pajkrt, E, Collaboration, EC. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. Bjog 2012; 119:778–87
Google Scholar | Crossref | Medline19. Ratsep, MT, Carmeliet, P, Adams, MA, Croy, BA. Impact of placental growth factor deficiency on early mouse implant site angiogenesis. Placenta 2014; 35:772–5
Google Scholar | Crossref | Medline20. Nishikawa, S, Miyamoto, A, Yamamoto, H, Ohshika, H, Kudo, R. The relationship between serum nitrate and endothelin-1 concentrations in preeclampsia. Life Sci 2000; 67:1447–54
Google Scholar | Crossref | Medline21. Haynes, WG, Noon, JP, Walker, BR, Webb, DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens 1993; 11:1375–80
Google Scholar | Crossref | Medline | ISI22. Yallampalli, C, Garfield, RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993; 169:1316–20
Google Scholar | Crossref | Medline23. Saito, Y, Nakao, K, Mukoyama, M, Imura, H. Increased plasma endothelin level in patients with essential hypertension. N Engl J Med 1990; 322:205
Google Scholar | Crossref | Medline24. Seremak-Mrozikiewicz, A, Barlik, M, Perlik, M, Kurzawinska, G, Drews, K. Genetic variability of endothelin-1 system in gestational hypertension and preeclampsia. Ginekol Pol 2011; 82:363–70
Google Scholar | Medline25. Masaki, T. Possible role of endothelin in endothelial regulation of vascular tone. Annu Rev Pharmacol Toxicol 1995; 35:235–55
Google Scholar | Crossref | Medline | ISI